SARIEF ET AL.
5
−1
ꢀ
NMR (500 MHz, CDCl3) δ 8.06 (s, 1H), 7.51 (s, 2H), 7.28
(s, 1H), 7.09 (s,1H), 2.14 (s, 3H): MS: m/z: 136.07 (M+1).
4-Nitroacetanilide (3i): mp 212–213 C; IR KBr, cm
:
3274 (NH of C=O), 1679 (C=O), 1373, 1179, 1089, 838:
1H-NMR (500 MHz, CDCl3) δ 8.21 (d, J = 8.9 Hz, 2H),
7.71 (d, J = 9.1 Hz, 2H), 7.70–7.60 (m, 1H), 2.25 (s, 3H).
13C-NMR (126 MHz, CDCl3) δ 168.95 (s) 152.57 (s),
139.10 (s), 126.38 (s), 125.08 (s), 119.00 (s), 113.39 (s),
24.78 (s). MS: m/z: 181.06 (M+1).
ꢀ
4-Methylaccetanilide (3b): mp 151–153 C; IR KBr,
cm−1: 3290 (NH of C=O), 1662 (C=O), 1366, 1169, 1027,
1
877. H-NMR (500 MHz, CDCl3) δ 7.76 (s, 1H), 7.37 (d,
J = 8.3 Hz, 2H), 7.09 (d, J = 8.1 Hz, 2H), 2.30 (s, 3H), 2.14
(s, 3H): 13C-NMR (126 MHz, CDCl3) δ 168.90 (s), 138.83
(s), 137.89 (s), 128.74 (s), 125.16 (s), 120.80 (s), 117.23 (s),
24.42 (s), 21.45 (s). MS: m/z: 150.09 (M+1).
4-Methyl-3-nitroacetanilide (3j): liquid; IR KBr, cm−1
:
3353 (NH of C=O), 1647 (C=O), 1369, 1168, 1065, 828.
1H-NMR (500 MHz, CDCl3) δ 8.11 (s, 1H), 7.80–7.64 (m,
2H), 7.27 (s, 1H), 5.00 (s, 1H), 2.55 (s, 3H), 2.21 (s, 3H).
MS: m/z: 195.07 (M+1).
ꢀ
2-Methylacetanilide (3c): mp 109–111 C; IR KBr,
cm−1: 3285 (NH of C=O), 1669 (C=O), 1362, 1181, 1013,
1
852. H-NMR (500 MHz, CDCl3) δ 7.83 (s, 1H), 7.35 (s,
1H), 7.30–7.25 (m, 1H), 7.17 (t, J = 7.8 Hz, 1H), 6.91 (d,
J = 7.5 Hz, 1H), 2.30 (s, 3H), 2.14 (s, 3H). 13C -NMR
(126 MHz, CDCl3) δ 168.73 (s), 135.43 (s), 133.93 (s),
129.42 (s), 120.24 (s), 24.36 (s), 20.86 (s). MS: m/z:
150.09 (M+1).
Phenylacetate (3k): Liquid; IR, KBr, cm−1: 1761
(C=O), 1369, 1184, 1052, 891. 1H-NMR (500 MHz,
CDCl3) δ 7.40–7.35 (m, 2H), 7.24–7.20 (m, 1H), 7.10–7.06
(m, 2H), 2.29 (s, 3H). 13C-NMR (126 MHz, CDCl3) δ
169.55 (s), 150.70 (s), 129.45 (s), 125.86 (s), 121.59 (s),
21.16 (s). MS: m/z: 137.06 (M+1).
4-Isopropylacetanilide (3d): Liquid; IR KBr, cm−1
:
3247 (NH of C=O), 1659 (C=O), 1369, 1180, 1053, 824.
1H-NMR (500 MHz, CDCl3) δ 7.59 (s, 1H), 7.40 (d,
J = 8.5 Hz, 2H), 7.16 (d, J = 8.4 Hz, 2H), 2.86 (dd,
J = 13.8, 6.9 Hz, 1H), 2.14 (s, 3H), 1.22 (d, J = 6.9 Hz,
6H). 13C-NMR (126 MHz, CDCl3) δ 168.55 (s), 145.03 (s),
135.63 (s), 126.83 (s), 120.26 (s), 33.59 (s), 24.42 (s), 24.01
(s). MS: m/z: 178.12 (M+1).
1-Naphtylacetate (3l): Liquid; IR, KBr, cm−1: 1720
(C=O), 1365, 1158, 1037, 875. 1H-NMR (500 MHz,
CDCl3) δ 7.83–7.75 (m, 2H), 7.67 (d, J = 8.3 Hz, 1H), 7.44
(dt, J = 5.4, 3.0 Hz, 2H), 7.41–7.37 (m, 1H), 7.17 (dd,
J = 7.5, 1.0 Hz, 1H), 2.39 (s, 3H). 13C-NMR (126 MHz,
CDCl3) δ 169.28 (s), 128.67 (s), 124.46 (d, J = 24.1 Hz),
120.54 (s), 120.31 (s), 120.04 (s), 24.33 (s). MS: m/z:
186.04 (M+1).
ꢀ
2,4-Dimethylacetanilide (3e): mp 128–130 C; IR KBr
cm−1: 3271 (NH of C=O), 1645 (C=O), 1364, 1160, 1036,
3-Chlorophenylacetate (3m): mp 212–213 C; IR,
ꢀ
1
1
874. H-NMR (500 MHz, CDCl3) δ 7.52 (d, J = 8.6 Hz,
KBr, cm−1: 1679 (C=O), 1373, 1179, 1089, 838. H-NMR
1H), 7.07 (d, J = 13.5 Hz, 1H), 7.00 (s, 2H), 2.29 (s, 3H),
2.21 (s, 3H), 2.19 (s, 3H). 13C-NMR (126 MHz, CDCl3) δ
168.59 (s), 135.32 (s), 132.91 (s), 131.18 (s), 130.05 (s),
127.27 (s), 124.02 (s), 24.10 (s), 20.89 (s), 17.76 (s). MS: m/
z: 164.10 (M+1).
(500 MHz, CDCl3) δ 7.30 (t, J = 8.1 Hz, 1H), 7.21 (ddd,
J = 8.1, 1.8, 1.0 Hz, 1H), 7.13 (t, J = 2.1 Hz, 1H), 7.00
(ddd, J = 8.2, 2.2, 0.9 Hz, 1H), 2.29 (s, 3H). MS: m/z:
171.48 (M+1).
2,6-Dichlorophenylacetate (3n): Liquid; IR KBr, cm−1
:
1
2,4,6-Trimethylacetanilide (3f ): Liquid; IR KBr cm−1
:
1775 (C=O), 1368, 1178, 1070, 887. H-NMR (500 MHz,
CDCl3) δ 7.34 (d, J = 8.1 Hz, 2H), 7.11 (t, J = 8.1 Hz, 1H),
2.39 (s, 3H). 13C-NMR (126 MHz, CDCl3) δ 167.28 (s),
144.09 (s), 128.94 (s), 128.63 (s), 127.15 (s), 20.21 (s). MS:
m/z: 206.05 (M+1).
3232(NH of C=O), 1665 (C=O), 1370, 1155, 1053, 862:
1H-NMR (500 MHz, CDCl3) δ 6.94 (s, 1H), 6.88 (s, 2H),
2.22 (s, 3H), 2.20 (s, 3H), 2.18 (s, 6H). 13C-NMR
(126 MHz, CDCl3) δ 169.21 (s), 138.18 (s), 137.20 (s),
136.16 (s), 135.24 (s), 131.13 (s), 129.33 (s), 128.93 (s),
22.97 (s), 20.94 (s), 18.27 (s): MS: m/z: 178.12 (M+1).
4-Chloroacetanilide (3g): mp 175–176 ꢀC; IR KBr,
cm−1: 3300 (NH of C=O), 1661 (C=O), 1370, 1179, 1086,
3-Chloro-4-Fluorophenyl acetate (3o): Liquid; IR KBr,
cm−1: 1735 (C=O), 1358, 1154, 1033, 871. 1H-NMR
(500 MHz, CDCl3) δ 7.19 (dd, J = 6.2, 2.8 Hz, 1H), 7.14 (t,
J = 8.7 Hz, 1H), 6.98 (ddd, J = 9.0, 3.9, 2.9 Hz, 1H), 2.29
(s, 3H). 13C-NMR (126 MHz, CDCl3) δ 168.64 9 s), 156.49
(s), 154.85 (s), 146.49 (s), 123.82 (s), 121.14 (s), 116.51 (s),
20.68 (s). MS: m/z: 198.02 (M+1).
1
838: H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 8.6 Hz,
2H), 7.28 (d, J = 11.0 Hz, 3H), 2.18 (s, 3H). 13C-NMR
(126 MHz, CDCl3) δ 168.29 (s), 136.42 (s), 129.31 (s),
129.02 (s), 121.08 (s), 24.57 (s). MS: m/z: 170.ꢀ03 (M+1).
4-Fluoroacetanilide (3h): mp 153–154 C; IR KBr,
cm−1: 3272 (NH of C=O), 1663 (C=O), 1367, 1158, 1055,
ꢀ
Aspirin (O-Acetylsalicylic acid) (3p): mp 133–134 C;
IR, KBr, cm−1: 2846, 1680 (C=O), 1303, 1134, 1077, 838.
1H-NMR (500 MHz, CDCl3) δ 8.12 (dd, J = 7.9, 1.7 Hz,
1H), 7.62 (td, J = 7.8, 1.7 Hz, 1H), 7.35 (td, J = 7.6, 0.9 Hz,
1H), 7.14 (dd, J = 8.1, 0.9 Hz, 1H), 2.35 (s, 3H). 13C-NMR
(126 MHz, CDCl3) δ 170.21 (s), 169.79 (s), 151.29 (s),
134.92 (s), 132.54 (s), 126.19 (s), 124.04 (s), 122.27 (s),
21.02 (s). MS: m/z: 181.13 (M+1).
1
859. H-NMR (500 MHz, CDCl3) δ 7.61 (s, 1H), 7.45 (dd,
J = 9.0, 4.8 Hz, 2H), 6.99 (t, J = 8.6 Hz, 2H), 2.16 (s, 3H).
13C-NMR (126 MHz, CDCl3) δ 168.80 (s), 160.42 (s),
158.48 (s), 121.97 (d, J = 7.9 Hz), 115.69 (s), 115.51 (s),
24.24 (s). MS: m/z: 154.06 (M+1).